Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.
Eyunni S, Mannan R, Zhang Y, Young E, Zhang Q, Luo J, Pang M, Mahapatra S, Tien JC, George JM, Jaber M, Hakkani H, Carson SE, Todd AJ, Hosseini N, Gondal M, Rebernick RJ, Cao X, Su F, Wang R, Mehra R, Li J, Cieslik M, Chinnaiyan AM, Parolia A. Eyunni S, et al. Among authors: mehra r. Science. 2025 Jun 26:eadv2367. doi: 10.1126/science.adv2367. Online ahead of print. Science. 2025. PMID: 40570057
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.
Iczkowski KA, De Marzo AM, Agarwal N, Berman DM, Cimadamore A, Fine SW, Greenland N, Khani F, Loda M, Lotan TL, Varma M, Chinnaiyan A, Giannarini G, Huang J, Montironi R, Netto GJ, Osunkoya AO, Ratliff T, Kristiansen G, Cheng L, van Leenders GJLH; Members of the ISUP GU Cancer Precursor Consensus Panel. Iczkowski KA, et al. Am J Surg Pathol. 2025 Jun 23. doi: 10.1097/PAS.0000000000002430. Online ahead of print. Am J Surg Pathol. 2025. PMID: 40545966
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer.
Burtness B, Flamand Y, Quon H, Weinstein GS, Mehra R, Garcia JJ, Kim S, O'Malley BW Jr, Ozer E, Ikpeazu C, Koch WM, Gross ND, Bell RB, Patel M, Lango MN, Morris LG, Smith R, Karakla D, Richmon JD, Holsinger FC, Ferris RL. Burtness B, et al. Among authors: mehra r. J Clin Oncol. 2025 Jun 10:JCO2402550. doi: 10.1200/JCO-24-02550. Online ahead of print. J Clin Oncol. 2025. PMID: 40493877
What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An International Neoadjuvant Kidney Cancer Consortium Delphi study.
Rossi SH, Choueiri TK, Jewett M, Jones JO, Laird A, Lewis B, Tippu Z, Van Der Mijn JCK, Bex A, Stewart GD; International Neoadjuvant Kidney Cancer Consortium (INKCC) members. Rossi SH, et al. Ann Oncol. 2025 Jun 4:S0923-7534(25)00769-0. doi: 10.1016/j.annonc.2025.05.540. Online ahead of print. Ann Oncol. 2025. PMID: 40480551 No abstract available.
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men.
Jia AY, Sun Y, Patel M, Baydoun A, Vince RA, Shoag JE, Brown JR, Barata PC, Schipper MJ, Dess RT, Jackson WC, Roy S, Nguyen PL, Berlin A, Mehra R, Schaeffer EM, Kashani R, Kishan AU, Zaorsky NG, Morgan TM, Spratt DE. Jia AY, et al. Among authors: mehra r. JCO Precis Oncol. 2025 Jun;9:e2400705. doi: 10.1200/PO-24-00705. Epub 2025 Jun 6. JCO Precis Oncol. 2025. PMID: 40479622
Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
Reddy YNV, Frantz RP, Hassoun PM, Hemnes A, Horn E, Leopold JA, Rischard F, Rosenzweig EB, Hill NS, Erzurum SC, Beck GJ, Finet JE, Jellis CL, Mathai SC, Mehra R, Tang WHW, Borlaug BA; PVDOMICS Study Group. Reddy YNV, et al. Among authors: mehra r. Circ Heart Fail. 2025 May 29:e012912. doi: 10.1161/CIRCHEARTFAILURE.125.012912. Online ahead of print. Circ Heart Fail. 2025. PMID: 40438933
1,214 results